Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hallal David
Relationship:   Director
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   2,920,473    

Indirect Shares

   17,647,006      
Direct Value   $38,917,709    

Indirect Value

   $33,839,013      
Total Shares   20,567,479      
Total Value   $72,756,722      


Alexion Pharmaceuticals Inc $34,541,045 Scholar Rock Holding Corp $2,763,558 Allovir Inc $1,613,106 Seer, Inc. $0 Alexion Pharmaceuticals Inc $34,541,045 Scholar Rock Holding Corp $2,763,558 Allovir Inc $1,613,106 Seer, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -113.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN CEO, Director 2016-08-08 189,266 2014-12-18 113,122    Premium*  
            Scholar Rock Holding Corp SRRK Director 2019-09-18 290,595 2019-09-18 0    Premium*  
            Allovir Inc ALVR 2024-06-06 2,143,662 2024-06-06 17,533,884    Premium*  
            Seer, Inc. SEER Director 2023-06-14 296,950 0    Premium*  
            Iteos Therapeutics, Inc. ITOS Director 2022-06-09 0 2021-12-20 0    Premium*  
* Premium Members only  

Records found :    128         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-07-30 4 S $110.86 $82,702 D/D (746) 88,908 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-08-05 4 S $116.87 $85,315 D/D (730) 88,178 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2014-01-29 4 S $133.37 $97,283 D/D (729) 108,949 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2014-02-03 4 S $157.14 $114,555 D/D (729) 108,220 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2014-02-04 4 S $153.63 $367,176 D/D (2,390) 105,830 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2014-02-06 4 S $156.95 $1,570 D/D (10) 113,965 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2014-02-07 4 S $155.55 $250,461 D/D (1,610) 113,965 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2014-08-04 4 S $158.00 $213,142 D/D (1,349) 118,616 0 -
ALXN Alexion Pharmaceuticals I... Chief Operating Officer   •       •      –    2014-11-03 4 S $190.00 $5,700,287 D/D (30,000) 118,616 0 -
ALXN Alexion Pharmaceuticals I... Chief Operating Officer   •       •      –    2015-02-03 4 S $174.02 $133,125 D/D (765) 117,851 0 -
ALXN Alexion Pharmaceuticals I... Chief Operating Officer   •       •      –    2015-02-04 4 S $174.38 $106,023 D/D (608) 117,243 0 -
ALXN Alexion Pharmaceuticals I... Chief Operating Officer   •       •      –    2015-02-09 4 S $173.93 $507,876 D/D (2,920) 126,013 0 -
ALXN Alexion Pharmaceuticals I... Chief Operating Officer   •       •      –    2015-02-10 4 S $171.15 $338,877 D/D (1,980) 124,033 0 -
ALXN Alexion Pharmaceuticals I... Chief Operating Officer   •       •      –    2015-03-02 4 S $180.34 $131,648 D/D (730) 132,858 0 -
ALXN Alexion Pharmaceuticals I... CEO   •       •      –    2015-08-04 4 S $196.52 $120,270 D/D (612) 143,516 0 -
ALXN Alexion Pharmaceuticals I... CEO   •       •      –    2015-08-07 4 S $190.01 $62,513 D/D (329) 143,187 0 -
ALXN Alexion Pharmaceuticals I... CEO   •       •      –    2016-02-04 4 S $143.81 $90,469 D/D (629) 142,558 0 -
ALXN Alexion Pharmaceuticals I... CEO   •       •      –    2016-02-05 4 S $140.49 $952,043 D/D (6,722) 176,972 0 -
ALXN Alexion Pharmaceuticals I... CEO   •       •      –    2016-02-08 4 S $138.02 $544,763 D/D (3,946) 173,026 0 -
ALXN Alexion Pharmaceuticals I... CEO   •       •      –    2016-02-29 4 S $138.91 $279,800 D/D (2,014) 191,012 0 -
ALXN Alexion Pharmaceuticals I... CEO   •       •      –    2016-04-01 4 S $135.87 $192,132 D/D (1,414) 189,598 0 -
ALXN Alexion Pharmaceuticals I... CEO   •       •      –    2016-08-08 4 S $137.14 $45,530 D/D (332) 189,266 0 -
ITOS Iteos Therapeutics, Inc. Director   –       •      –    2021-12-20 4 S $43.57 $2,178,500 D/D (50,000) 0 0 -
ALVR Allovir Inc Director   –       •       •   2022-01-24 4 S $8.01 $136,889 D/D (17,100) 2,213,566 0 %
ITOS Iteos Therapeutics, Inc. Director   –       •      –    2022-06-08 4 S $19.86 $574,367 D/D (28,444) 0 0 -
  128  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us